Efficacy and Safety of Oral Administration of a Mixture of Probiotic Strains in Patients with Psoriasis: A Randomized Controlled Clinical Trial

The aim of this 12-week randomized, double-blind, placebo-controlled trial was to determine the efficacy and safety of a probiotic mixture in the reduction of psoriasis severity. Ninety 18-70-year-old adults with plaque psoriasis were randomized into probiotic and placebo groups. At 12-week follow-u...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta dermato-venereologica 2019-11, Vol.99 (12), p.1078-1084
Hauptverfasser:	Navarro-López, Vicente, Martínez-Andrés, Asunción, Ramírez-Boscá, Ana, Ruzafa-Costas, Beatriz, Núñez-Delegido, Eva, Carrión-Gutiérrez, Miguel A, Prieto-Merino, David, Codoñer-Cortés, Francisco, Ramón-Vidal, Daniel, Genovés-Martínez, Salvador, Chenoll-Cuadros, Empar, Pérez-Orquín, José M, Picó-Monllor, José A, Chumillas-Lidón, Sara
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adolescent Adult Aged dermatology Double-Blind Method Female Gastrointestinal Microbiome Humans Male microbiome microbiota Middle Aged probiotic Probiotics - administration & dosage Probiotics - adverse effects psoriasis Psoriasis - diagnosis Psoriasis - immunology Psoriasis - microbiology Psoriasis - therapy Recurrence Remission Induction Spain Time Factors Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The aim of this 12-week randomized, double-blind, placebo-controlled trial was to determine the efficacy and safety of a probiotic mixture in the reduction of psoriasis severity. Ninety 18-70-year-old adults with plaque psoriasis were randomized into probiotic and placebo groups. At 12-week follow-up, 66.7% of patients in the probiotic group and 41.9% in the placebo group showed a reduction in Psoriasis Area and Severity Index of up to 75% (p
ISSN:	0001-5555 1651-2057
DOI:	10.2340/00015555-3305